Day Two (14th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
- Geoffrey Pot - General Manager Operations, Site Head, Takeda
- Michael Butler - Principal Investigator, Cell Technology, NIBRT
- Gearóid Duane - Principal Scientist, Manufacturing Science & Technology Upstream, Bristol Myers Squibb, Cruiserath Biologics
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Cleo Kontoravdi - Professor, Imperial College London
- Rui Manuel Freitas Oliveira - Associate Professor of Chemical and Biochemical Engineering, School of Science and Engineering Universidade Nova de Lisboa
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Julian Hitzler - Senior Expert Science & Technology, Drug Substance Development, Novartis Pharma
Choosing the Right Strategy: Factors to Consider Based on Your Production Process
- Multi-column chromatography
- Process intensification
Increasing capacity while maintaining product quality
Real-world examples: demonstrating increased capacity and product quality
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Hans-Rainer Voelger - Senior Scientist, Roche Diagnostics GmbH
- Petra Sebastian - Senior Scientist, Biopharmaceutical Product Development Bioanalytical Sciences, CSL Innovation GmbH
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Kyle Grant - Director of Vector Production, Voyager Therapeutics
Limitations of viral vectors & need for alternatives
Emerging non-viral delivery tech:
- LNPs, exosomes, CPPs
How novel approaches/systems can aid in:
- Safety, reduced immunogenicity, larger payloads
Utilizing new systems for existing pipelines
Analytical challenges associated with characterisation and ensuring the safety/efficacy of non-viral delivery systems
- Bernd Giebel - Founder & CTO, Exosla Therapeutics
- Lior Shaltiel - CEO, NurExone Biologic
- David Kuntin - CEO, Mesenbio
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Veronique Chotteau, PhD - Professor Mammalian Cell-based Bioprocess Technology, KTH - Royal Institute of Technology
- Amandine Calvet - Lab Manager, Boehringer Ingelheim
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Thomas Berger, MSc - PhD student, Department of Biosciences and Medical Biology, University of Salzburg
- Rolf Kohler - Group Lead, Novartis Pharma
- Harnessing continuous downstream processing for biopharmaceutical production.
- The implementation of Process Analytical Technologies (PAT) in continuous downstream operations.
- Technologies and applications for continuous bioprocessing.
- What does this hold for the future of continuous processing?
Cross-team collaboration: integrate sustainability principles across the downstream spectrum
Industry collaboration to drive sustainability across the biopharma industry
The Regulatory Landscape: Navigating EMA and MHRA requirements and view for Sustainable Solutions
Minimizing biological load in waste streams: strategies and best practices
The Role of Innovation: developing new technologies and approaches for a greener future
The importance of facility design for achieving sustainable manufacturing goals
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- A Representative from BioPhorum - -, BioPhorum
- Jayanth Sridhar - CEO and Global Head of Biologics, Dr Reddy’s Laboratories Ltd.
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Dieter Palmberger - CTO, bespark*bio
- Guido Moll - Assistant Coordinator EU-H2020 ATMP & GMP Projects, Charité, Universitätsmedizin Berlin, Germany
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
By leveraging cell therapy processing technology, we can address the challenge of scaling up cell production for mass consumption. Utilization of a proprietary, cost-effective micro-carrier formulation that surpasses conventional, pharma-focused options in both price and food industry compatibility. This innovation unlocks unprecedented scalability and efficiency for both cultivated meat and cell therapy applications.